Baş Firdevs, Darendeliler Feyza, Yapici Zuhal, Gökalp Selman, Bundak Rüveyde, Saka Nurçin, Günöz Hülya
Pediatric Endocrinology Unit, Department of Pediatrics, Istanbul Faculty of Medicine, Istanbul University, Turkey.
J Pediatr Endocrinol Metab. 2006 Apr;19(4):535-40.
Worster-Drought syndrome (WDS) (congenital bilateral perisylvian syndrome, congenital pseudobulbar paresia) is characterized by neuronal migration defect, pseudobulbar paralysis, epilepsy, neuromotor retardation and perisylvian dysplasia. We report a patient with WDS associated with posterior pituitary ectopia, pituitary hypoplasia, partial empty sella and panhypopituitarism, not previously reported in the literature. The 16.4 year-old female patient had severe growth retardation with height SDS -4.5, delayed puberty, microcephaly, pes equinovarus deformity, developmental delay, speech disorder and epilepsy. Laboratory findings, which revealed abnormal electroencephalography and bilateral perisylvian cortical dysplasia on cranial magnetic resonance imaging (MRI) were consistent with WDS. Endocrinological evaluation revealed secondary hypothyroidism and combined deficiency of adrenocorticotropin, gonadotropin and growth hormone (GH). Sella MRI showed congenital empty sella, anterior pituitary hypoplasia, ectopic neurohypophysis, and stalk agenesis. Appropriate replacement therapy was started. GH treatment resulted in a final height of 150.3 cm, appropriate for her target height. This is the first reported patient with WDS associated with congenital structural hypothalamic-pituitary abnormalities, including empty sella, pituitary hypoplasia, posterior pituitary ectopia, stalk agenesis and panhypopituitarism. GH has been successful in the treatment of her short stature.
沃斯特-德劳特综合征(WDS)(先天性双侧外侧裂周综合征、先天性假性延髓麻痹)的特征为神经元迁移缺陷、假性延髓麻痹、癫痫、神经运动发育迟缓及外侧裂周发育异常。我们报告了1例伴有垂体后叶异位、垂体发育不全、部分空蝶鞍及全垂体功能减退的WDS患者,此前文献未见报道。该16.4岁女性患者有严重生长迟缓,身高标准差评分(SDS)为-4.5,青春期延迟,小头畸形,马蹄内翻足畸形,发育迟缓,言语障碍及癫痫。实验室检查结果显示脑电图异常,头颅磁共振成像(MRI)显示双侧外侧裂周皮质发育异常,与WDS相符。内分泌评估显示继发性甲状腺功能减退以及促肾上腺皮质激素、促性腺激素和生长激素(GH)联合缺乏。蝶鞍MRI显示先天性空蝶鞍、垂体前叶发育不全、异位神经垂体及垂体柄缺如。开始进行适当的替代治疗。GH治疗使患者最终身高达到150.3 cm,符合其靶身高。这是首例报道的伴有先天性下丘脑-垂体结构异常(包括空蝶鞍、垂体发育不全、垂体后叶异位、垂体柄缺如及全垂体功能减退)的WDS患者。GH成功治疗了她的身材矮小问题。